Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Clinical trial NCT07251413 · RECRUITING
Trial details
- NCT number
- NCT07251413
- Sponsor
- Instituto Oncológico Dr Rosell
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-22
- Primary completion
- 2028-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.